Familial type 3 hyperlipoproteinemia: genes and variants
Explore variant evidence for Familial type 3 hyperlipoproteinemia across 1 analyzed protein (APOE). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 4 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial type 3 hyperlipoproteinemia
APOE: Apolipoprotein E
It redistributes cholesterol and other lipids between tissues by directing remnant lipoproteins to LDL-receptor-family members. The common epsilon4 isoform strongly increases late-onset Alzheimer disease risk and also influences plasma lipids and cardiovascular risk.
10 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in APOE have source records linked to Familial type 3 hyperlipoproteinemia. Association strength is not clinical gene validity.
Where Familial type 3 hyperlipoproteinemia variants cluster
- APOE 4 (positions 146–167): 5 of 10 ClinVar pathogenic / likely pathogenic variants, 7.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Familial type 3 hyperlipoproteinemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| APOE R154S | 154 | 4 | Pathogenic / likely pathogenic (★★★★) |
| APOE R154H | 154 | 4 | Pathogenic / likely pathogenic (★) |
| APOE R160C | 160 | 4 | Pathogenic / likely pathogenic (★) |
| APOE G183A | 183 | 5 | Pathogenic / likely pathogenic (★) |
| APOE R163C | 163 | 4 | Pathogenic / likely pathogenic |
| APOE K164E | 164 | 4 | Pathogenic / likely pathogenic |
| APOE E31K | 31 | Pathogenic / likely pathogenic | |
| APOE R176C | 176 | 5 | Pathogenic / likely pathogenic |
| APOE R269G | 269 | Homooligomerization | Pathogenic / likely pathogenic |
| APOE C130R | 130 | 3 | Pathogenic / likely pathogenic |
Diseases related to Familial type 3 hyperlipoproteinemia
- Familial hypercholesterolemia, also linked to APOE
- Alzheimer disease, also linked to APOE
- Type 2 diabetes mellitus, also linked to APOE
- Hyperlipoproteinemia, also linked to APOE
- Age related macular degeneration, also linked to APOE
- Diabetes mellitus, also linked to APOE
- Lewy body dementia, also linked to APOE
- Myocardial infarction, also linked to APOE
- Autosomal dominant Alzheimer disease, also linked to APOE
- Dementia, also linked to APOE
- Lipoprotein glomerulopathy, also linked to APOE
Frequently asked questions
Which genes have records linked to Familial type 3 hyperlipoproteinemia?
This view contains 1 analyzed proteins: APOE. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 4 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 16 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center